SynthesisMedicine2022

Poziotinib in non-small-cell lung cancer patients with HER2 exon 20 mutations: A pooled analysis of randomized clinical trials.

Bi-Cheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.